Neha Vora

Research Director

See Full Clinical Trials Team
Neha Vora

Education

  • Master of Science in Nursing (MSN), APRN
    Vanderbilt University, Nashville, Tennessee (2025)
  • Bachelor of Science in Nursing (BSN), RN
    Bellarmine University, Louisville, Kentucky (2023)
  • Western Kentucky University, Bowling Green, Kentucky (2018)
  • Bachelor of Science in Biology
    Kentucky Wesleyan College, Owensboro, Kentucky (2015)

Experience

  • BI 456906 – Cardiovascular safety study in overweight or obese patients with comorbidities
  • LIBREXIA-AF – Milvexian vs Apixaban in Atrial Fibrillation
  • TA-8995-304 Prevail – Obicetrapib in ASCVD
  • BP-24-001 – COVID-19 vaccination immunologic correlates study
  • VICTORION-1 PREVENT – Inclisiran for primary prevention of cardiovascular events
  • KARDIA-3 – Zilebesiran in patients with hypertension
  • ADG20 EVADE – COVID-19 prevention with ADG20
  • AZALEA – Abelacimab vs Rivaroxaban in AF
  • AZD3427 – Safety and pharmacokinetics in heart failure patients
  • SEL-212 – Gout treatment study
  • PURSUIT – Viveve RF SUI trial
  • CLN-301 – Tolperisone for back muscle spasm
  • ZOLL HF – µCor treatment in heart failure
  • RM08-3009 – Nitazoxanide for common cold
  • RM08-3008 – Nitazoxanide for mild/moderate COVID-19
  • MATISSE – RSV vaccine in infants (Pfizer)
  • CATCH-HF – Heart failure biomarker characterization
  • PAT-CR-302 – Patiromer for hyperkalemia
  • Orion 4 – Inclisiran cardiovascular outcome study
  • ORESA – T89 angina treatment
  • SAGE-217 (SAGE 301) – Severe postpartum depression treatment
  • Brexanolone (SAGE 304) – Adolescent PPD safety study
  • VITALITY – Vericiguat in HF with preserved EF
  • Evaluate HF – Sacubitril/valsartan vs enalapril for central aortic stiffness
  • TRAVERSE – Testosterone therapy cardiovascular impact
  • AMPLITUDE – Efpeglenatide cardiovascular outcomes in Type 2 Diabetes
  • PROVE-HF – Sacubitril/valsartan biomarker study
  • ZOLL 90D0109 – Heart Failure Optimization Study
  • R-Pharm CREDO 3 – Olokizumab in RA, TNF-alpha resistant
  • R-Pharm CREDO 2 – Olokizumab in RA, methotrexate resistant
  • R-Pharm CREDO 4 – Open-label Olokizumab safety study
  • COL-MIG 305 (Gladiator) – Lasmiditan migraine safety study
  • COL-MIG 302 (Spartan) – Lasmiditan migraine dose study
  • BL 400-303 – Chronic use of BLI400 laxative in adults

Training & Qualifications

  •  ACLS: current certificate holder 
  • GCP CITI: current certificate holder
  • IATA: computer training; current certificate holder
  • CPR: BLS certificate
  • EDC Experience: sponsor training; includes Medidata Rave, DataLabs, InForm, Oracle, and Perspective MyTrials (6 yrs)
  • Questionnaires: sponsor/national training; includes PAC-QOL, PAC-SYM, Disease Severity, Disease QOL, Global Symptom Relief, Global Pain Relief, MIDAS, PHQ-9, HIS-Q, IPSS
  • EKG Acquisitions: site training per cardiologist; lead placement per sponsor recommendations; conducting for 6 yrs
  • Electronic Diaries: sponsor- and vendor-provided training
  • EKG Transmission: per sponsor & vendor training; both computer/phone line (6 yrs)
  • CSSR-S: Sponsor & national training; certificate may be available (6 yrs)
  • Vitals: include temp, wt, ht, BP, HR; site training; manual/automatic BP; oral, temporal, auricle temp (6 yrs)
  • IXRS: sponsor training; Bracket, Perspective MyTrials (6 yrs)
  • Centrifuge training: by site including cup size, RPMs, and calibrations (6 yrs)
  • Lab Sample Processing: sponsor, central lab specific, local lab & site training (6 yrs)
  • ERT Site Pad: training per sponsor/vendor (6 yrs)
  • Rapid Result Labs: include drug screening, nicotine, pregnancy, urine dip stick (6 yrs)
  • Consenting Patients
  • Inclusion/Exclusion review
  • Patient Recruitment
  • Patient Retention
  • Obtain Medical Records for PI review
  • Maintain study supplies
  • Watch over Rights and Welfare of the Patients
  • PK Ice Baths: preparing samples
  • PHT experience
  • Transmission of ultrasound, x-ray, CT scan, nuclear medicine, echo, and DXA via DICOM
  • Assist in audits (sponsor and/or FDA)
  • Attends Investigator Meetings
  • Monitor/Maintain temperature logs
  • Maintain Drug Logs
  • Dispense IP
  • Assist the PI in delegated duties
  • Administering questionnaires per protocol
  • Entering data into eCRF
  • Resolving queries
  • Protocol adherence
  • Creating and completing source documentation
  • Drawing and processing of labs
  • Infusion pump settings
  • Blinded/Unblinded Pharmacist experience

Learn More About Your Care Team

View All Providers